Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
| Actual shortage: | 30 (23%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2020-08-19 | 2020-11-11 | 122507 |
| MINT-CITALOPRAM | 40MG | TABLET | Resolved | 2020-04-27 | 2020-11-11 | 113285 |
| MINT-FLUOXETINE | 10MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57064 |
| MINT-FLUOXETINE | 20MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57069 |
| MINT-RAMIPRIL | 15.0MG | CAPSULE | Resolved | 2020-08-19 | 2021-01-11 | 122510 |
| MINT-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108295 |
| MINT-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108298 |
| MINT-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108301 |
| MINT-LACOSAMIDE | 50MG | TABLET | Resolved | 2021-01-11 | 2021-02-23 | 131336 |
| MINT-ONDANSETRON | 8MG | TABLET | Resolved | 2021-01-11 | 2021-03-23 | 131330 |
| MINT-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2021-01-11 | 2021-04-05 | 131333 |
| MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2021-01-11 | 2021-06-22 | 131327 |
| MINT-IRBESARTAN | 150MG | TABLET | Resolved | 2019-04-08 | 2021-07-12 | 80800 |
| MINT-IRBESARTAN | 300MG | TABLET | Resolved | 2019-04-08 | 2021-07-12 | 80803 |
| MINT-IRBESARTAN | 75MG | TABLET | Resolved | 2019-01-03 | 2021-07-12 | 71063 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300.0MG | TABLET | Resolved | 2019-01-16 | 2021-08-11 | 72666 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150.0MG | TABLET | Resolved | 2019-04-08 | 2021-08-11 | 80792 |
| MINT-IRBESARTAN/HCTZ | 25.0MG 300.0MG | TABLET | Resolved | 2019-04-08 | 2021-08-11 | 80797 |
| MINT-CIPROFLOX | 250MG | TABLET | Resolved | 2020-04-25 | 2022-06-06 | 113184 |
| MINT-CIPROFLOX | 750MG | TABLET | Resolved | 2020-08-19 | 2022-06-06 | 122502 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-FENOFIBRATE E | 145MG | TABLET | Discontinued | 2020-04-25 | 2020-04-25 | 113175 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MINT-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170853 |
| MINT-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170856 |
| MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
| MINT-CITALOPRAM | 20MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191439 |
| MINT-CITALOPRAM | 40MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191442 |